Research Article
Prevalence of Hepatitis C Virus Seropositivity and Its Impact on Coronary Artery Disease among Egyptian Patients Referred for Coronary Angiography
Table 2
Demographic and clinical characteristics of the HCV-positive and HCV-negative groups.
| Variable | Group 1A HCV positive ()
| Group 1B HCV negative ()
| value |
| Age (years) | 54.08 ± 8.37 | 53.52 ± 8.37 | 0.556 |
| Gender | | | | (i) Male (%) | 66 (55.9%) | 129 (57.1%) | 0.838 | (ii) Female (%) | 52 (44.1%) | 97 (42.9%) |
| Risk factors | | | | (i) DM | 41 (34.7%) | 134 (59.3%) | <0.0001 | (ii) HTN | 63 (53.4%) | 167 (73.9%) | <0.0001 | (iii) Dyslipidemia | 80 (67.8%) | 149 (65.9%) | 0.727 | (iv) Smokers | 45 (38.1%) | 108 (47.8%) | 0.087 | (v) Positive family history | 29 (24.6%) | 52 (23%) | 0.745 |
|
|
CAD = coronary artery disease, = number, = mean, SD = standard deviation, DM = diabetes mellitus, HTN = hypertension, and EF = ejection fraction.
|